Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sacramento, CA
NPI
1104026558
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4241 Florin Rd Ste 30&40
Sacramento, CA, 95823
Phone (916) 737-5555
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
3,993 prescriptions
Company payments, 2025
$415
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug I-Tsyr Shaw prescribed most often to Medicare patients was Ozempic (Semaglutide), with 533 prescriptions and refills. In total I-Tsyr Shaw wrote 3,993 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 533 | 694 | 93 | $615K |
| Metformin Hcl Generic | 362 | 702 | 95 | $1,986 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 316 | 487 | 85 | $40K |
| Jardiance Empagliflozin | 272 | 487 | 62 | $263K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 242 | 344 | 71 | $101K |
| Levothyroxine Sodium Generic | 202 | 445 | 46 | $4,920 |
| Humalog Kwikpen U-100 Insulin Lispro | 169 | 218 | 46 | $38K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 152 | 351 | 67 | $13K |
| Januvia Sitagliptin Phosphate | 122 | 214 | 38 | $103K |
| Trulicity Dulaglutide | 91 | 128 | 18 | $119K |
| Metformin Hcl Er Metformin Hcl | 86 | 176 | 23 | $345 |
| Glipizide Generic | 80 | 124 | 18 | $466 |
| Pioglitazone Hcl Generic | 78 | 155 | 18 | $1,054 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 76 | 147 | 30 | $7,796 |
| Methimazole Generic | 65 | 140 | 15 | $636 |
Brand drugs: 2,462 claims; generic drugs: 988 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid I-Tsyr Shaw $415 ($415 in general payments such as food, travel and fees) from 10 companies. The largest payer was Novo Nordisk Inc with $93.83.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 4 | $93.83 |
| Amgen Inc. AMGN | 4 | $80.45 |
| Lilly USA, LLC LLY | 3 | $53.21 |
| Abbott Laboratories ABT | 2 | $52.65 |
| Exact Sciences Corporation EXAS | 1 | $31.28 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $29.56 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $27.17 |
| Mannkind Corporation MNKD | 1 | $17.76 |
| LNHC, Inc | 1 | $14.85 |
| Phadia US Inc. | 1 | $14.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.